Please assess the completion status of the following clinical trial:

Trial Title: KAVIAR Study - Kyphoplasty And Vertebroplasty In the Augmentation and Restoration of Vertebral Body Compression Fractures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~All subjects must meet all of the following criteria to be enrolled into the study:~1. Age \> 21~2. 1 to 3 target VCFs meeting the following criteria:~   1. Fracture due to diagnosed or presumed underlying primary or secondary osteoporosis~  2. All target VCFs are between T5 and L5~  3. All target VCFs to be treated show either: i. Height change: An acute (\< 6 month) change in VB height or morphology from a previous x-ray, CT or MRI, with height loss at the anterior, middle or posterior portion of the VB consistent with a worsening of 1 or more grades by the Genant criteria (17), OR ii. Positive MRI or bone scan: VB shows hyperintense signal on STIR sequence MRI or target VB is positive on radionuclide bone scan~  4. All VCFs to be treated have fracture age (time from pain onset to evaluation by the Investigator) of 6 months or less~  5. Back pain correlating with the location of at least one VCF~3. Treatment of all target VCFs is technically feasible by and clinically appropriate for BOTH vertebroplasty and balloon kyphoplasty. (Team approach only: Both the vertebroplasty and balloon kyphoplasty physician have reviewed radiographic studies and agree to this prior to enrolling the subject in the study.)~4. Pre-treatment back pain by numerical rating scale (NRS) score \> 4 (0-10 scale)~5. Pre-treatment Oswestry Disability Index \>20 (0 - 100 scale)~6. Subject states availability for all study visits~7. Subject is able to understand the risks and benefits of participating in the study and is willing to provide written informed consent~8. Subject has mental capacity to comply with the protocol requirements for 2-year duration of study~Exclusion Criteria~Subjects who meet any of the following conditions may not be enrolled into the study:~1. VB morphology or configuration is such that either balloon kyphoplasty OR vertebroplasty is not technically feasible for the targeted VCFs~2. Fracture due to high-energy trauma~3. Suspected OR proven cancer inside index vertebral body. Note that patients with chemotherapy-related osteoporosis may be included.~4. Disabling back pain due to causes other than acute fracture (e.g., sacroiliac fracture, symptomatic degenerative disc disease, lumbar spinal stenosis)~5. Any painful VCF with fracture age \> 6 months~6. Any objective evidence of neurologic compromise at baseline~7. Previous balloon kyphoplasty or vertebroplasty for any VCF~8. Spine stabilization beyond balloon kyphoplasty or vertebroplasty required for targeted VCFs~9. Significant clinical comorbidity that may potentially interfere with long-term data collection or follow-up (e.g., dementia, severe comorbid illness)~10. Pre-existing conditions contrary to either balloon kyphoplasty or vertebroplasty, such as:~    1. Irreversible coagulopathy or bleeding disorder. Note regarding reversible coagulopathies: Subjects on coumadin or other anticoagulants may participate. Investigators should follow routine practices for perioperative discontinuation and re-initiation of anticoagulants.~   2. Allergy to any device materials (e.g., bone cement) for balloon kyphoplasty or vertebroplasty. Note that in subjects with allergy to iodine-based contrast, other non-iodine contrast solutions may be used.~   3. Any evidence of VB or systemic infection~11. Pregnant or child-bearing potential

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Kyphoplasty (Type: ACTIVE_COMPARATOR): None
- Vertebroplasty (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).